Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Ludwig Enterprises, Inc. develops genomic and mRNA-based health diagnostics focused on early detection of inflammation-related chronic diseases such as cancer, heart disease, and autoimmune disorders. Utilizing proprietary genetic biomarkers, machine learning AI, and saliva or blood samples, the company aims to provide personalized, preventative healthcare tools and diagnostic tests. Its business model includes developing laboratory-developed tests (LDTs), consumer screening kits, and conducting clinical research to improve disease management and treatment outcomes.
This description was generated via AI from an annual report. Updated about 1 year ago.